Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 11, 313-317, May 1, 1951]
© 1951 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bloch, H. S.
Right arrow Articles by Doran, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bloch, H. S.
Right arrow Articles by Doran, M. J.

The Distribution of S35 from Labeled DL-Methionine in Mice Bearing Carcinoma of the Breast, Neoplasms of the Hematopoietic System, or Liver Abscesses*

Henry S. Bloch, Claude R. Hitchcock{dagger}, Arnold J. Kremen and Margaret J. Doran

( Department of Surgery, The Medical School, University of Minnesota, Minneapolis 14, Minn.)

The distribution of S35 in mice bearing mammary carcinomas, lymphosarcomas, leukemias, or liver abscesses was studied 24 hours after an intraperitoneal injection of DL-methionine-S35. The concentration of the isotope was highest in the intestinal wall and liver, lowest in muscle; it was considerably higher in protein fractions than in nonprotein fractions of the tissues. The concentration of S35 in the wet tumor tissue was lower than that in the wet liver tissue of the same animals; but the concentration of the isotope in the proteins of lymphosarcomas was equal to or greater than that in the liver proteins from the same animals. The fact that the S35 in wet lymphosarcoma tissue is lower than in wet liver tissue is probably due to the low protein content of lymphosarcomas. In contrast to that in tumors, the concentration of S35 in liver abscesses was very low. On the premise that the concentration of a radioactive isotope in tumor tissue must be much higher than in other tissues of the body if the isotope is to be useful in the treatment of neoplastic diseases, the data reported here do not favor methionine-S35 as a possible therapeutic agent for mammary carcinomas, lymphosarcomas, or leukemias.

* This investigation was aided by the American Cancer Society Institutional Research Grant, No. INSTR-49.

{dagger} Postdoctorate Research Fellow, National Cancer Institute, Public Health Service.

Received 11/ 1/50.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1951 by the American Association for Cancer Research.